Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Author(s)
O'Day, Elizabeth; Hosta-Rigau, Leticia; Oyarzún, Diego A.; Okano, Hideyuki; de Lorenzo, Víctor; ... Show more
Thumbnail
DownloadAccepted version (276.6Kb)
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.
Date issued
2018-05
URI
https://hdl.handle.net/1721.1/126515
Department
McGovern Institute for Brain Research at MIT; Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences; Massachusetts Institute of Technology. Department of Biological Engineering
Journal
Biotechology Journal
Publisher
Wiley
Citation
O'Day, Elizabeth et al. "Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health." Biotechology Journal 14, 1 (January 2019): 1800195 © 2018 WILEY-VCH Verlag GmbH & Co.
Version: Author's final manuscript
ISSN
1860-6768
Collections